5-177210239-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022455.5(NSD1):​c.1840G>T​(p.Val614Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.138 in 1,597,604 control chromosomes in the GnomAD database, including 19,804 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V614M) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.14 ( 1923 hom., cov: 31)
Exomes 𝑓: 0.14 ( 17881 hom. )

Consequence

NSD1
NM_022455.5 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.285

Publications

58 publications found
Variant links:
Genes affected
NSD1 (HGNC:14234): (nuclear receptor binding SET domain protein 1) This gene encodes a protein containing a SET domain, 2 LXXLL motifs, 3 nuclear translocation signals (NLSs), 4 plant homeodomain (PHD) finger regions, and a proline-rich region. The encoded protein enhances androgen receptor (AR) transactivation, and this enhancement can be increased further in the presence of other androgen receptor associated coregulators. This protein may act as a nucleus-localized, basic transcriptional factor and also as a bifunctional transcriptional regulator. Mutations of this gene have been associated with Sotos syndrome and Weaver syndrome. One version of childhood acute myeloid leukemia is the result of a cryptic translocation with the breakpoints occurring within nuclear receptor-binding Su-var, enhancer of zeste, and trithorax domain protein 1 on chromosome 5 and nucleoporin, 98-kd on chromosome 11. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Sep 2018]
NSD1 Gene-Disease associations (from GenCC):
  • Beckwith-Wiedemann syndrome due to NSD1 mutation
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Sotos syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • Sotos syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.2281436E-5).
BP6
Variant 5-177210239-G-T is Benign according to our data. Variant chr5-177210239-G-T is described in ClinVar as Benign. ClinVar VariationId is 96042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.493 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022455.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NSD1
NM_022455.5
MANE Select
c.1840G>Tp.Val614Leu
missense
Exon 5 of 23NP_071900.2
NSD1
NM_001409301.1
c.1840G>Tp.Val614Leu
missense
Exon 5 of 23NP_001396230.1
NSD1
NM_001409302.1
c.1840G>Tp.Val614Leu
missense
Exon 5 of 23NP_001396231.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NSD1
ENST00000439151.7
TSL:1 MANE Select
c.1840G>Tp.Val614Leu
missense
Exon 5 of 23ENSP00000395929.2
NSD1
ENST00000347982.9
TSL:1
c.967G>Tp.Val323Leu
missense
Exon 6 of 24ENSP00000343209.5
NSD1
ENST00000687453.1
c.1531G>Tp.Val511Leu
missense
Exon 2 of 20ENSP00000508426.1

Frequencies

GnomAD3 genomes
AF:
0.135
AC:
20563
AN:
151934
Hom.:
1926
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0764
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.170
Gnomad ASJ
AF:
0.112
Gnomad EAS
AF:
0.510
Gnomad SAS
AF:
0.248
Gnomad FIN
AF:
0.188
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.122
Gnomad OTH
AF:
0.122
GnomAD2 exomes
AF:
0.179
AC:
42796
AN:
239304
AF XY:
0.176
show subpopulations
Gnomad AFR exome
AF:
0.0748
Gnomad AMR exome
AF:
0.235
Gnomad ASJ exome
AF:
0.112
Gnomad EAS exome
AF:
0.517
Gnomad FIN exome
AF:
0.184
Gnomad NFE exome
AF:
0.118
Gnomad OTH exome
AF:
0.154
GnomAD4 exome
AF:
0.138
AC:
199439
AN:
1445552
Hom.:
17881
Cov.:
38
AF XY:
0.140
AC XY:
100517
AN XY:
717724
show subpopulations
African (AFR)
AF:
0.0681
AC:
2228
AN:
32718
American (AMR)
AF:
0.222
AC:
9307
AN:
41956
Ashkenazi Jewish (ASJ)
AF:
0.113
AC:
2861
AN:
25208
East Asian (EAS)
AF:
0.504
AC:
19906
AN:
39504
South Asian (SAS)
AF:
0.217
AC:
18176
AN:
83920
European-Finnish (FIN)
AF:
0.185
AC:
9817
AN:
52932
Middle Eastern (MID)
AF:
0.117
AC:
660
AN:
5662
European-Non Finnish (NFE)
AF:
0.116
AC:
127646
AN:
1104158
Other (OTH)
AF:
0.149
AC:
8838
AN:
59494
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
9425
18849
28274
37698
47123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4934
9868
14802
19736
24670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.135
AC:
20564
AN:
152052
Hom.:
1923
Cov.:
31
AF XY:
0.143
AC XY:
10662
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.0762
AC:
3160
AN:
41486
American (AMR)
AF:
0.170
AC:
2598
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.112
AC:
390
AN:
3470
East Asian (EAS)
AF:
0.510
AC:
2619
AN:
5140
South Asian (SAS)
AF:
0.248
AC:
1197
AN:
4818
European-Finnish (FIN)
AF:
0.188
AC:
1994
AN:
10584
Middle Eastern (MID)
AF:
0.0850
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
0.122
AC:
8269
AN:
67978
Other (OTH)
AF:
0.123
AC:
260
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
857
1714
2571
3428
4285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.128
Hom.:
7185
Bravo
AF:
0.130
TwinsUK
AF:
0.107
AC:
398
ALSPAC
AF:
0.108
AC:
417
ESP6500AA
AF:
0.0704
AC:
310
ESP6500EA
AF:
0.114
AC:
982
ExAC
AF:
0.174
AC:
21135
Asia WGS
AF:
0.332
AC:
1151
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 10, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Mar 19, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Sotos syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
0.0070
DANN
Benign
0.53
DEOGEN2
Benign
0.060
T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.060
N
LIST_S2
Benign
0.64
T
MetaRNN
Benign
0.000092
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.26
N
PhyloP100
-0.28
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.47
N
REVEL
Benign
0.19
Sift
Benign
0.32
T
Sift4G
Benign
0.91
T
Polyphen
0.0020
B
Vest4
0.14
MutPred
0.14
Loss of MoRF binding (P = 0.0946)
MPC
0.054
ClinPred
0.0017
T
GERP RS
-1.3
Varity_R
0.024
gMVP
0.16
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3733875; hg19: chr5-176637240; COSMIC: COSV61771212; COSMIC: COSV61771212; API